NFKB1 and atherosclerosis: We have demonstrated that they decrease NF-kB activation and MCP-1 expression and reduce the macrophage infiltrate in experimental atherosclerosis [65], and many studies have confirmed these anti-inflammatory effects of statins and other lipid-lowering drugs [66].